Back to Top
  • Congratulations to Editorial Board Member Gregg L. SemenzaProfessor of Genetic Medicine at The Johns Hopkins University School of Medicine!  Dr. Semenza was jointly awarded the Nobel Prize in Physiology or Medicine with two other scientists, William G. Kaelin Jr. and Peter J. Ratcliffe, for their collective work on how cells sense oxygen and adapt to changes in oxygen availability.  Dr. Semenza discovered the Hypoxia Inducible Factor-1 (HIF-1) transcriptional complex in 1995 and has since then demonstrated the importance of this pathway in maintaining cellular oxygen homeostasis and in the pathology of cancer,  cerebral and myocardial ischemia and chronic lung disease.   

Aims & Scope

Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.

ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.

ARS coverage includes:

  • ROS/RNS as messengers
  • Gaseous signal transducers
  • Hypoxia and tissue oxygenation
  • microRNA
  • Prokaryotic systems
  • Lessons from plant biology

ARS is under the editorial leadership of Editor-in-Chief Chandan K. Sen, PhD, Indiana University School of Medicine, and other leading investigators. View the entire editorial board.

Audience: Cell biologists, molecular biologists, biochemists, medical researchers, and nutritionists, among others.

ARS provides "Instant Online" publication 72 hours after acceptance.
Average time to first decision: 16 days
Average time to triage decision: 48 hours


  • PubMed/MEDLINE
  • PubMed Central
  • Science Citation Index®
  • Scopus
  • Current Contents®/Life Sciences
  • Biochemistry & Biophysics Citation Index®
  • Biological Abstracts
  • BIOSIS Previews
  • Journal Citation Reports/Science Edition
  • EMBASE/Excerpta Medica
  • EMBiology
  • Chemical Abstracts
  • ProQuest databases
  • SafetyLit
  • BenchSci
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.